T Deuse

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint Twenty-year survivors of heart transplantation at Stanford University
    T Deuse
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA, USA
    Am J Transplant 8:1769-74. 2008
  2. doi request reprint Heart-lung transplantation in situs inversus totalis
    Tobias Deuse
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California 94305, USA
    Ann Thorac Surg 88:1002-3. 2009
  3. doi request reprint Granulocyte colony-stimulating factor therapy is associated with a reduced incidence of acute rejection episodes or allograft vasculopathy in heart transplant recipients
    B Vrtovec
    Division of Cardiovascular Medicine, Stanford University, Stanford, California, USA
    Transplant Proc 45:2406-9. 2013
  4. doi request reprint Changing trends in infectious disease in heart transplantation
    Francois Haddad
    Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford University, Stanford, California 94305, USA
    J Heart Lung Transplant 29:306-15. 2010
  5. doi request reprint Right ventricular dysfunction predicts poor outcome following hemodynamically compromising rejection
    Francois Haddad
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Palo Alto, California 94305 5406, USA
    J Heart Lung Transplant 28:312-9. 2009
  6. doi request reprint ST-elevation myocardial infarction following heart transplantation as an unusual presentation of coronary allograft vasculopathy: a case report
    S Peter
    Stanford University Hospital, Stanford, Calif 94305 5110, USA
    Transplant Proc 45:787-91. 2013
  7. ncbi request reprint Effect of inhaled tacrolimus on cellular and humoral rejection to prevent posttransplant obliterative airway disease
    S Schrepfer
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA, USA
    Am J Transplant 7:1733-42. 2007
  8. doi request reprint Novel immunosuppression: R348, a JAK3- and Syk-inhibitor attenuates acute cardiac allograft rejection
    Tobias Deuse
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA
    Transplantation 85:885-92. 2008
  9. doi request reprint Non-volume-loaded heart provides a more relevant heterotopic transplantation model
    Karis R Tang-Quan
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, USA
    Transpl Immunol 23:65-70. 2010
  10. doi request reprint A novel JAK3 inhibitor, R348, attenuates chronic airway allograft rejection
    Jeffrey B Velotta
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA
    Transplantation 87:653-9. 2009

Collaborators

Detail Information

Publications14

  1. doi request reprint Twenty-year survivors of heart transplantation at Stanford University
    T Deuse
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA, USA
    Am J Transplant 8:1769-74. 2008
    ..5% of patients transplanted before 1988. Although still associated with considerable morbidity, long-term survival is expected to occur at much higher rates in the future due to major advances in the field over the past decade...
  2. doi request reprint Heart-lung transplantation in situs inversus totalis
    Tobias Deuse
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California 94305, USA
    Ann Thorac Surg 88:1002-3. 2009
    ..Here we present our simplified surgical technique for combined heart-lung transplantation and provide a concise review of the literature...
  3. doi request reprint Granulocyte colony-stimulating factor therapy is associated with a reduced incidence of acute rejection episodes or allograft vasculopathy in heart transplant recipients
    B Vrtovec
    Division of Cardiovascular Medicine, Stanford University, Stanford, California, USA
    Transplant Proc 45:2406-9. 2013
    ..We evaluated the potential effects of granulocyte colony-simulating factor (G- CSF) on the incidence of rejection and allograft vasculopathy in heart transplant recipients...
  4. doi request reprint Changing trends in infectious disease in heart transplantation
    Francois Haddad
    Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford University, Stanford, California 94305, USA
    J Heart Lung Transplant 29:306-15. 2010
    ..This study presents a historical perspective of the changing trends of infectious disease after heart transplantation...
  5. doi request reprint Right ventricular dysfunction predicts poor outcome following hemodynamically compromising rejection
    Francois Haddad
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Palo Alto, California 94305 5406, USA
    J Heart Lung Transplant 28:312-9. 2009
    ..Right ventricular (RV) function is a strong predictor of outcome in patients with heart failure and myocarditis. The objective of the current study is to determine whether RV dysfunction predicts event-free survival in patients with HCR...
  6. doi request reprint ST-elevation myocardial infarction following heart transplantation as an unusual presentation of coronary allograft vasculopathy: a case report
    S Peter
    Stanford University Hospital, Stanford, Calif 94305 5110, USA
    Transplant Proc 45:787-91. 2013
    ..Herein, we present a unique case of STEMI years after heart transplantation with a focus on the salient features of its diagnosis and interventions. We also provide a review of the epidemiology of this phenomenon...
  7. ncbi request reprint Effect of inhaled tacrolimus on cellular and humoral rejection to prevent posttransplant obliterative airway disease
    S Schrepfer
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA, USA
    Am J Transplant 7:1733-42. 2007
    ..5-fold) graft infiltration on POD 8 compared to PO (p < 0.001). Tacrolimus aerosol reduces systemic side effects and effectively protects the airway graft from early cellular rejection and chronic obliterative airway disease...
  8. doi request reprint Novel immunosuppression: R348, a JAK3- and Syk-inhibitor attenuates acute cardiac allograft rejection
    Tobias Deuse
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA
    Transplantation 85:885-92. 2008
    ..Janus kinase (JAK)3 is crucial for signal transduction downstream of various cytokine receptors in immune cells. This is the first report on the novel JAK3 inhibitor R348...
  9. doi request reprint Non-volume-loaded heart provides a more relevant heterotopic transplantation model
    Karis R Tang-Quan
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, USA
    Transpl Immunol 23:65-70. 2010
    ..Non-volume-loaded (NL) and volume-loaded (VL) models were tested for their physiologic and immunologic properties to assess their suitability for transplant studies...
  10. doi request reprint A novel JAK3 inhibitor, R348, attenuates chronic airway allograft rejection
    Jeffrey B Velotta
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA
    Transplantation 87:653-9. 2009
    ..This study aimed at investigating the role of a novel JAK3 inhibitor, R348, in the prevention of chronic airway allograft rejection...
  11. doi request reprint Mechanisms behind local immunosuppression using inhaled tacrolimus in preclinical models of lung transplantation
    Tobias Deuse
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA
    Am J Respir Cell Mol Biol 43:403-12. 2010
    ..In conclusion, TAC can be delivered easily and effectively into the lungs without causing airway toxicity, decreases inflammatory AE cytokine production, and inhibits NFκB activation...
  12. doi request reprint Review of heart-lung transplantation at Stanford
    Tobias Deuse
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California, USA
    Ann Thorac Surg 90:329-37. 2010
    ..Further options to treat infections and strategies to control bronchiolitis obliterans syndrome, the main causes of early and long-term mortality, respectively, are required to achieve routine long-term survival...
  13. doi request reprint Prevention and inhibition but not reversion of chronic allograft vasculopathy by FK778
    Tobias Deuse
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA
    Transplantation 85:870-7. 2008
    ..This study aimed at investigating the efficacy of the novel immunosuppressant FK778 to prevent the development and progression of chronic allograft vasculopathy (CAV)...
  14. doi request reprint Alternative technique for salvage of donor lungs with insufficient atrial cuffs
    William M Yarbrough
    Department of Cardiothoracic Surgery, Stanford University Medical Center, Falk Cardiovascular Research Center, Stanford, California 94305 5407, USA
    Ann Thorac Surg 88:1374-6. 2009
    ....